Pular para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Adalimumab treatment with and...
  • Citar
  • Enviar por SMS
  • Enviar por e-mail
  • Imprimir
  • Exportar registro
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Link permanente
Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept

Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept

Detalhes bibliográficos
Principais autores: Kavanaugh, A, Ritchlin, C, Malaise, MG, Wordsworth, P, Birbara, C, Weinberg, M
Formato: Conference item
Publicado em: 2005
  • Itens
  • Descrição
  • Registros relacionados
  • Registro fonte

Registros relacionados

  • Radiographic efficacy of adalimumab in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use and clinical response: subanalysis of adept
    por: Choy, E, et al.
    Publicado em: (2007)
  • Effectiveness and safety of adalimumab in treating moderate to severe psoriasis patients with psoriatic arthritis in Taiwan
    por: Pei-Han Kao, et al.
    Publicado em: (2015-09-01)
  • Adalimumab in treatment of psoriatic arthritis
    por: V. V. Badokin
    Publicado em: (2008-08-01)
  • Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
    por: Mease, P, et al.
    Publicado em: (2017)
  • Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity
    por: Landewé, R, et al.
    Publicado em: (2019)

Opções de Busca

  • Histórico de buscas
  • Busca Avançada

Encontrar Mais

  • Navegar o acervo
  • Navegar por ordem alfabética
  • Explorar canais
  • Bibliografia Recomendada
  • Novos itens

Precisa de ajuda?

  • Dicas de Busca
  • Serviço de Referência
  • Perguntas Frequentes